Sionna Stock 144% This Year: Is the Biotech a Buy Now?
Sionna Therapeutics has surged 144% over the past year, drawing attention from growth-minded investors. This article ...
Redeeming credit card points can be tricky. Discover what to avoid to ensure you make the most out of your rewards and benefits.
19,422 articlesSionna Therapeutics has surged 144% over the past year, drawing attention from growth-minded investors. This article ...
The VIX surges about 10% as Brent breaches the $100 mark, signaling rising fear among traders and a shift toward risk...
APM’s Michael Banner says HECM for Purchase has failed to take off due to industry shortcomings rather than product f...
Micron Technology posted a strong quarter but faced a sharp pullback as investors priced in a tougher near-term path....
Two popular consumer staples ETFs—FSTA and FTXG—offer different routes to defense in a volatile market. This guide br...
Investors are watching whether NVIDIA back business China could unlock a new revenue stream. This analysis covers sce...
A fresh court filing broadens a veteran-focused mortgage case, accusing Veterans United of bait-and-switch tactics an...
Vice Capital Markets launches a public daily Par Note Rate benchmark, providing a market-based view of mortgage prici...
Stocks all-time highs still attract buyers as earnings momentum and AI-driven demand support another leg up. Here's t...
Qualcomm exploded higher, gaining about 70% in a single month as it pivots toward AI data-center demand. Investors ar...
A wave of budget-conscious shoppers is steering growth at discount grocers, reshaping grocery traffic and profits. An...
A senior policy voice close to U.S. foreign affairs says Washington may have a strategic setback in Iran, signaling t...